Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,708 | -1,961 | -1,318 | -1,381 | -1,202 |
| Depreciation Amortization | 64 | 0 | 0 | 0 | N/A |
| Accounts receivable | -48 | N/A | N/A | N/A | N/A |
| Other Working Capital | 291 | 65 | -154 | -169 | 1,014 |
| Other Operating Activity | 1,515 | 1,188 | 872 | 1,235 | 5 |
| Operating Cash Flow | $-886 | $-708 | $-600 | $-314 | $-182 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -14 | -2 | -2 | N/A |
| Investing Cash Flow | $-18 | $-14 | $-2 | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 75 | 75 | 75 | 75 | 75 |
| Debt Issued | 370 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 608 | 666 | 686 | 538 | -30 |
| Financing Cash Flow | $1,053 | $741 | $761 | $613 | $45 |
| Beginning Cash Position | 14 | 14 | 14 | 14 | 152 |
| End Cash Position | 163 | 33 | 173 | 312 | 14 |
| Net Cash Flow | $148 | $19 | $158 | $298 | $-138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -886 | -708 | -600 | -314 | -182 |
| Capital Expenditure | -18 | -14 | -2 | -2 | N/A |
| Free Cash Flow | -904 | -722 | -602 | -316 | -182 |